Structural motif descriptors as a way to elucidate the agonistic or antagonistic activity of growth hormone-releasing hormone peptide analogues

Kevin Jeanne Dit Fouque, Luis M. Salgueiro, Renzhi Cai, Wei Sha, Andrew V Schally, Francisco Fernandez-Lima

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The synthesis of analogues of hypothalamic neuropeptide growth hormone-releasing hormone (GHRH) is an efficient strategy for designing new therapeutic agents. Several promising synthetic agonist and antagonist analogues of GHRH have been developed based on amino acid mutations of the GHRH (1-29) sequence. Because structural information on the activity of the GHRH agonists or antagonists is limited, there is a need for more effective analytical workflows capable of correlating the peptide sequence with biological activity. In the present work, three GHRH agonists-MR-356, MR-406, and MR-409- A nd three GHRH antagonists-MIA-602, MIA-606, and MIA-690-were investigated to assess the role of substitutions in the amino acid sequence on structural motifs and receptor binding affinities. The use of high resolution trapped ion mobility spectrometry coupled to mass spectrometry allowed the observation of a large number of peptide-specific mobility bands (or structural motif descriptors) as a function of the amino acid sequence and the starting solution environment. A direct correlation was observed between the amino acid substitutions (i.e., basic residues and d/l-amino acids), the structural motif descriptors, and the biological function (i.e., receptor binding affinities of the GHRH agonists and antagonists). The simplicity, ease, and high throughput of the proposed workflow based on the structural motif descriptors can significantly reduce the cost and time during screening of new synthetic peptide analogues.

Original languageEnglish (US)
Pages (from-to)7432-7440
Number of pages9
JournalACS Omega
Volume3
Issue number7
DOIs
StatePublished - Jul 6 2018

Fingerprint

Growth Hormone-Releasing Hormone
Hormones
Peptides
Amino Acids
Amino acids
Substitution reactions
Trapped ions
Hormone Antagonists
Bioactivity
Peptide Hormones
Neuropeptides
Spectrometry
Mass spectrometry
Screening
Throughput

ASJC Scopus subject areas

  • Chemistry(all)
  • Chemical Engineering(all)

Cite this

Structural motif descriptors as a way to elucidate the agonistic or antagonistic activity of growth hormone-releasing hormone peptide analogues. / Jeanne Dit Fouque, Kevin; Salgueiro, Luis M.; Cai, Renzhi; Sha, Wei; Schally, Andrew V; Fernandez-Lima, Francisco.

In: ACS Omega, Vol. 3, No. 7, 06.07.2018, p. 7432-7440.

Research output: Contribution to journalArticle

Jeanne Dit Fouque, Kevin ; Salgueiro, Luis M. ; Cai, Renzhi ; Sha, Wei ; Schally, Andrew V ; Fernandez-Lima, Francisco. / Structural motif descriptors as a way to elucidate the agonistic or antagonistic activity of growth hormone-releasing hormone peptide analogues. In: ACS Omega. 2018 ; Vol. 3, No. 7. pp. 7432-7440.
@article{22a80b9fe8694c958c27946be0c1a705,
title = "Structural motif descriptors as a way to elucidate the agonistic or antagonistic activity of growth hormone-releasing hormone peptide analogues",
abstract = "The synthesis of analogues of hypothalamic neuropeptide growth hormone-releasing hormone (GHRH) is an efficient strategy for designing new therapeutic agents. Several promising synthetic agonist and antagonist analogues of GHRH have been developed based on amino acid mutations of the GHRH (1-29) sequence. Because structural information on the activity of the GHRH agonists or antagonists is limited, there is a need for more effective analytical workflows capable of correlating the peptide sequence with biological activity. In the present work, three GHRH agonists-MR-356, MR-406, and MR-409- A nd three GHRH antagonists-MIA-602, MIA-606, and MIA-690-were investigated to assess the role of substitutions in the amino acid sequence on structural motifs and receptor binding affinities. The use of high resolution trapped ion mobility spectrometry coupled to mass spectrometry allowed the observation of a large number of peptide-specific mobility bands (or structural motif descriptors) as a function of the amino acid sequence and the starting solution environment. A direct correlation was observed between the amino acid substitutions (i.e., basic residues and d/l-amino acids), the structural motif descriptors, and the biological function (i.e., receptor binding affinities of the GHRH agonists and antagonists). The simplicity, ease, and high throughput of the proposed workflow based on the structural motif descriptors can significantly reduce the cost and time during screening of new synthetic peptide analogues.",
author = "{Jeanne Dit Fouque}, Kevin and Salgueiro, {Luis M.} and Renzhi Cai and Wei Sha and Schally, {Andrew V} and Francisco Fernandez-Lima",
year = "2018",
month = "7",
day = "6",
doi = "10.1021/acsomega.8b00375",
language = "English (US)",
volume = "3",
pages = "7432--7440",
journal = "ACS Omega",
issn = "2470-1343",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Structural motif descriptors as a way to elucidate the agonistic or antagonistic activity of growth hormone-releasing hormone peptide analogues

AU - Jeanne Dit Fouque, Kevin

AU - Salgueiro, Luis M.

AU - Cai, Renzhi

AU - Sha, Wei

AU - Schally, Andrew V

AU - Fernandez-Lima, Francisco

PY - 2018/7/6

Y1 - 2018/7/6

N2 - The synthesis of analogues of hypothalamic neuropeptide growth hormone-releasing hormone (GHRH) is an efficient strategy for designing new therapeutic agents. Several promising synthetic agonist and antagonist analogues of GHRH have been developed based on amino acid mutations of the GHRH (1-29) sequence. Because structural information on the activity of the GHRH agonists or antagonists is limited, there is a need for more effective analytical workflows capable of correlating the peptide sequence with biological activity. In the present work, three GHRH agonists-MR-356, MR-406, and MR-409- A nd three GHRH antagonists-MIA-602, MIA-606, and MIA-690-were investigated to assess the role of substitutions in the amino acid sequence on structural motifs and receptor binding affinities. The use of high resolution trapped ion mobility spectrometry coupled to mass spectrometry allowed the observation of a large number of peptide-specific mobility bands (or structural motif descriptors) as a function of the amino acid sequence and the starting solution environment. A direct correlation was observed between the amino acid substitutions (i.e., basic residues and d/l-amino acids), the structural motif descriptors, and the biological function (i.e., receptor binding affinities of the GHRH agonists and antagonists). The simplicity, ease, and high throughput of the proposed workflow based on the structural motif descriptors can significantly reduce the cost and time during screening of new synthetic peptide analogues.

AB - The synthesis of analogues of hypothalamic neuropeptide growth hormone-releasing hormone (GHRH) is an efficient strategy for designing new therapeutic agents. Several promising synthetic agonist and antagonist analogues of GHRH have been developed based on amino acid mutations of the GHRH (1-29) sequence. Because structural information on the activity of the GHRH agonists or antagonists is limited, there is a need for more effective analytical workflows capable of correlating the peptide sequence with biological activity. In the present work, three GHRH agonists-MR-356, MR-406, and MR-409- A nd three GHRH antagonists-MIA-602, MIA-606, and MIA-690-were investigated to assess the role of substitutions in the amino acid sequence on structural motifs and receptor binding affinities. The use of high resolution trapped ion mobility spectrometry coupled to mass spectrometry allowed the observation of a large number of peptide-specific mobility bands (or structural motif descriptors) as a function of the amino acid sequence and the starting solution environment. A direct correlation was observed between the amino acid substitutions (i.e., basic residues and d/l-amino acids), the structural motif descriptors, and the biological function (i.e., receptor binding affinities of the GHRH agonists and antagonists). The simplicity, ease, and high throughput of the proposed workflow based on the structural motif descriptors can significantly reduce the cost and time during screening of new synthetic peptide analogues.

UR - http://www.scopus.com/inward/record.url?scp=85059627314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059627314&partnerID=8YFLogxK

U2 - 10.1021/acsomega.8b00375

DO - 10.1021/acsomega.8b00375

M3 - Article

AN - SCOPUS:85059627314

VL - 3

SP - 7432

EP - 7440

JO - ACS Omega

JF - ACS Omega

SN - 2470-1343

IS - 7

ER -